Welcome to LookChem.com Sign In|Join Free
  • or
(4-chloro-2-fluoro-phenyl)-carbaMic acid tert-butyl ester, also known as tert-butyl (4-chloro-2-fluorophenyl)carbaMate, is an organic compound synthesized from the reaction of 4-chloro-2-fluoroaniline and di-tert-butyl dicarbonate. It is characterized by its unique structure and reactivity, making it a versatile intermediate in organic synthesis and a valuable building block in the pharmaceutical industry for the production of various drugs and pharmaceutical compounds.

956828-47-0

Post Buying Request

956828-47-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

956828-47-0 Usage

Uses

Used in Pharmaceutical Industry:
(4-chloro-2-fluoro-phenyl)-carbaMic acid tert-butyl ester is used as a building block for the synthesis of various pharmaceutical compounds due to its unique structure and reactivity. It plays a crucial role in the development of new drugs and the improvement of existing ones.
Used in Organic Synthesis:
(4-chloro-2-fluoro-phenyl)-carbaMic acid tert-butyl ester is used as a versatile intermediate in organic synthesis, enabling the creation of a wide range of organic compounds with diverse applications.
Used in Research and Development:
(4-chloro-2-fluoro-phenyl)-carbaMic acid tert-butyl ester is utilized in research and development for the exploration of new chemical compounds and the investigation of its unique properties and potential applications in different industries.

Check Digit Verification of cas no

The CAS Registry Mumber 956828-47-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,6,8,2 and 8 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 956828-47:
(8*9)+(7*5)+(6*6)+(5*8)+(4*2)+(3*8)+(2*4)+(1*7)=230
230 % 10 = 0
So 956828-47-0 is a valid CAS Registry Number.

956828-47-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Carbamic acid, N-(4-chloro-2-fluorophenyl)-, 1,1-dimethylethyl ester

1.2 Other means of identification

Product number -
Other names (4-chloro-2-fluoro-phenyl)-carbaMic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:956828-47-0 SDS

956828-47-0Downstream Products

956828-47-0Relevant academic research and scientific papers

QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

-

Paragraph 0648; 0649; 0650, (2016/04/19)

The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, W1, W2, W3, and R1-R6 are described herein.

FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

-

Paragraph 0131, (2016/11/14)

The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula (I) where A, B, U, V, Z, W1, W2, W3, and R1-R6 are described herein.

QUINOLINONE FIVE-MEMBERED HETEROCYCLIC COMPOUNDS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

-

Paragraph 0541; 0542; 0543, (2016/11/14)

The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where Y1, X1, X2, Y

TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1

-

Page/Page column 48, (2008/06/13)

The present invention relates to tetra-substituted urea compounds which are modulators of 11-β hydroxyl steroid dehydrogenase type 1 (11β HSD1), their pharmaceutical compositions, and methods of using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 956828-47-0